Literature DB >> 8127037

Erythropoietin: the promise and the facts.

J W Eschbach1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8127037

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  4 in total

1.  A decision analysis comparing three dosage regimens of subcutaneous epoetin in continuous ambulatory peritoneal dialysis.

Authors:  A Piccoli; R M Puggia; M Fusaro; E Favaro; L Pillon
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

2.  De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease.

Authors:  Bradley A Warady; John Barcia; Nadine Benador; Augustina Jankauskiene; Kurt Olson; Ludmila Podracka; Aleksey Shavkin; Poyyapakkam Srivaths; Cynthia J Wong; Jeffrey Petersen
Journal:  Pediatr Nephrol       Date:  2017-08-17       Impact factor: 3.714

Review 3.  Recombinant erythropoietin in clinical practice.

Authors:  T Ng; G Marx; T Littlewood; I Macdougall
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

4.  Erythropoietin use and abuse.

Authors:  M Joseph John; Vineeth Jaison; Kunal Jain; Naveen Kakkar; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2012-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.